Top Markets
Coin of the day
PCI Biotech Holding ASA PCI Biotech Holding ASA

PCI Biotech Holding ASA

PCIB
株式のランク #40012
PCI Biotech Holding ASA, an Oslo, Norway-based biopharmaceutical firm, is... PCI Biotech Holding ASA, an Oslo, Norway-based biopharmaceutical firm, is focused on pioneering and bringing to market innovative treatments for cancer. At the core of their operations is the proprietary photochemical internalization (PCI) technology platform. The company's development pipeline features several distinct therapeutic strategies: fimaCHEM, a novel approach to chemotherapeutic cancer treatment; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is currently in Phase I clinical studies; and fimaNAc, a delivery system for nucleic acid therapeutics, presently in its pre-clinical phase. Furthermore, they provide Amphinex, a photosensitizer known as fimaporfin. PCI Biotech actively participates in joint research endeavors with partners such as Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense.
株価
$0.00733708
最終同期: 2026-04-23
時価総額
$273.87K
変化(1日)
-39.13%
変化(1年)
-94.83%
NO
取引 PCI Biotech Holding ASA (PCIB)

カテゴリー

PCI Biotech Holding ASA(PCIB)の株式分割履歴
PCI Biotech Holding ASA株(シンボル:PCIB)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 14, 2026に行われました。
Aug 14, 2026より前に購入されたPCIB株は、現在0PCIB株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE